Table 2.

Participant demographics, lymph node characteristics, and the summary of the performance of quantitative HDMI biomarkers

	Reactive (n = 34)	Metastatic (n = 34)	p-valueb
Age (y)	55.06 ± 12.93	56.6 ± 13.04	0.73
ALN size (mm)	22 ± 6	24 ± 6	0.0135
Cortical thickness (mm)	4.8 ± 2.0	7.7 ± 4.4	< 0.001
HDMI Biomarkers
(DMmean)τmean	1.03 ± 0.03	1.04 ± 0.02	0.005
(DMmax)τmax	1.14 ± 0.16	1.27 ± 0.22	0.00017
NV	9.56 ± 7.96	24.65 ± 23.13	< 0.00001
NB	4.00 ± 1.19	13.59 ± 16.44	0.00001
VD	0.03 ± 0.02	0.06 ± 0.04	0.00018
VDR	4.94 ± 4.84	2.35 ± 1.73	0.02
mvFD	1.17 ± 0.11	1.29 ± 0.10	< 0.00001
μm Dmax	548.73 ± 106.89	566.03 ± 0.38	0.13
μm Dmean	450.41 ± 86.49	449.39 ± 0.31	0.49
MDmax	0.46 ± 0.27	0.64 ± 0.23	0.007
MDmean	0.31 ± 0.16	0.32 ± 0.07	0.40
MDmin	0.18 ± 0.17	0.08 ± 0.09	0.003
BAmax	114.63 ± 23.60	135.40 ± 11.24	0.006
BAmean	101.28 ± 18.36	101.03 ± 11.24	0.92
BAmin	85.37 ± 27.73	62.80 ± 28.39	0.004

Unless otherwise specified, Data are presented as mean ± standard deviation

ª Data are numbers of participants

^b Wilcoxon rank-sum test

Numbers in bold indicate statistical significance, i.e., p-value < 0.05